- Home
- PINS vs QGEN Comparison
PINS vs QGEN Comparison
Compare PINS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PINS | QGEN |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 10.2B |
| IPO Year | 2019 | 1998 |
Fundamental Metrics
Financial Performance| Metric | PINS | QGEN |
|---|---|---|
| Price | $22.42 | $39.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 8 |
| Target Price | $26.78 | ★ $45.76 |
| AVG Volume (30 Days) | ★ 13.8M | 2.2M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 7.17% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,221,767,000.00 | N/A |
| Revenue This Year | $14.48 | $8.18 |
| Revenue Next Year | $12.04 | $5.71 |
| P/E Ratio | ★ N/A | $24.01 |
| Revenue Growth | ★ 15.79 | N/A |
| 52 Week Low | $13.84 | $32.53 |
| 52 Week High | $39.93 | $57.82 |
Technical Indicators
Market Signals| Indicator | PINS | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 60.69 | 57.72 |
| Support Level | $17.67 | $38.80 |
| Resistance Level | $27.86 | $49.27 |
| Average True Range (ATR) | 0.96 | 0.79 |
| MACD | 0.20 | 0.12 |
| Stochastic Oscillator | 84.90 | 71.93 |
Price Performance
Historical ComparisonAbout PINS Pinterest Inc.
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).